Opinion

Video

The Role of Biomarker Testing in the Management of Metastatic Melanoma

Expert panelists stress the importance of biomarker testing for BRAF mutations to guide treatment options when a patient is diagnosed with metastatic melanoma.

Related Videos
Thach-Giao Truong, MD, medical director, Melanoma Program, Cleveland Clinic
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Alexander C. Van Akkooi, MD, PhD, FRACS
Meredith McKean, MD